Contact Us

TOURISM NEWS

Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

Oct 20, 2024

GOTHENBURG,Sweden,Oct. 18,2024-- "The order intake increased by 10.0%,of which organic growth was 7.4%. All regions reported a positive performance," saysMattias Perjos,President & CEO a

Kroll Liquidators Secured Multi-Million Dollar Settlement Between Emergent Fidelity Technologies and FTX Estate Approved by US Bankruptcy Court

Oct 20, 2024

NEW YORK,Oct. 18,2024-- Kroll,the leading independent provider of global financial and risk advisory solutions,announced today that a multi-million dollar settlement between the liquidators of Emerge

LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing

Oct 20, 2024

Phase 1 trial of LM-299,an anti-PD-1/VEGF BsAb,initiated in China for advanced solid tumors following promising preclinical results demonstrating strong inhibition of tumor growth and well-tolerated s

Kerry Logistics Network Garners Three Accolades at the HKQAA Green and Sustainable Finance Awards 2024

Oct 20, 2024

HONG KONG,Oct. 18,2024-- Kerry Logistics Network Limited (\'Kerry Logistics Network\',\'KLN\'; Stock Code 0636.HK) is honoured to receive three accolades for its contributions to sustainable financean

China sees prospering development of marine economy

Oct 20, 2024

BEIJING,Oct. 18,2024-- A report from People\'s Daily: Marine-related industries are creating abundant new opportunities for China\'s economy. In 2023,the GDP of China\'s marine economy exceeded 9.9 tr

MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum

Oct 20, 2024

SAN FRANCISCO,Oct. 18,2024-- Dr.Regis Vilchez,Chief Medical Officer of MicuRx Pharmaceuticals,presented the latest advancements of company\'s development program,MRX-5 and MRX-8,at the BIO Investor Fo

1 ... 135 136 137 138 139 140 141 ... 235